Explore the groundbreaking research funded by the Cure for Cancer Foundation, focused on advancing treatments for kidney, bladder, and prostate cancer.
Every year, thousands of individuals receive a diagnosis of kidney, bladder, prostate cancer, significantly impacting their lives and the lives of their loved ones.
By investing in research, we aim to develop more effective treatments and improve the quality of life for patients battling these cancers. We collaborate with leading research institutions, both nationally and internationally, including Amsterdam UMC hospitals and Johns Hopkins Institute, to leverage expertise and resources in our fight against cancer.
Developing advanced, non-invasive diagnostic tools to identify bladder cancer earlier, improving treatment outcomes.
Exploring alternative therapies, including new instillations or medications for superficial bladder cancer.
Investigating the effectiveness of immunotherapy to enhance treatment options for bladder cancer patients.
Focusing on the long-term well-being of patients through tailored care strategies and better follow-up protocols.
Supporting studies into cutting-edge therapies, including immunotherapy and targeted treatments, to improve survival rates and minimise side effects.
Developing advanced diagnostic tools to identify kidney cancer earlier, increasing the chances of successful treatment.
Pioneering less invasive techniques, such as freezing therapies, which reduce recovery times and improve patient outcomes.
Investigating the long-term effects of kidney cancer treatments to optimise patient care and support.
Prostate cancer is one of the most common cancers in men, with thousands of new cases diagnosed every year. Fortunately, there are many treatment options available and most men with prostate cancer can live long lives despite their diagnosis. However, to ensure the best outcomes and quality of life for patients, early detection, the right treatment at the right time and appropriate follow-up care are needed. Research plays a vital role in improving each step of this process.
At Cure for Cancer, we are committed to advancing kidney cancer research by:
Detecting prostate cancer at the right time is crucial. Research aims to enhance PSA test accuracy, reducing unnecessary tests for healthy men while ensuring timely diagnosis and treatment for those in need.
We are exploring Transperineal Focal Laser Ablation (TPLA) as a less invasive alternative for treating localised prostate cancer. PSMA PET/CT scans are also being investigated to guide targeted therapies for metastatic cases, aiming to expand options, improve outcomes, and preserve quality of life. Prostate cancers vary in behaviour, from aggressive to slow-growing. Research like PSMA PET/CT scans helps tailor treatments, improving outcomes while avoiding unnecessary procedures. This increases treatment options, improves outcomes and preserves quality of life.
Prostate cancers vary in behavior, from aggressive to slow-growing. Research, such as PSMA PET/CT scans, helps fine-tune treatments, improving outcomes and avoiding unnecessary interventions.
physician-researchers
Our dedicated researchers are advancing the understanding and treatment of prostate, kidney, bladder, and upper tract urothelial cancers. Collaborating with leading institutions, they focus on early detection, innovative therapies, and personalised care to improve patient outcomes, all made possible by your support. They collaborate with leading institutions. Their focus is on early detection, innovative therapies and personalized care to improve patient outcomes. All of this is made possible by your support.
The result of your donations
Explore the groundbreaking research funded by Cure for Cancer, published in leading journals, advancing early detection, treatments, and patient care for prostate, kidney, bladder, and urothelial cancers.
Our dedicated researchers, Katelijne de Bie, Rosemarijn Ettema, Luna van den Brink, Marinka Remmelink, and Orlane Figaroa, presented their findings at the European Multidisciplinary Congress on Urological Cancers (EMUC24) in Lisbon last week.
This unique interdisciplinary event brought together leading experts in oncology, urology, pathology, and radiology to discuss the latest advancements in genito-urinary cancer treatment. Our researchers proudly contributed to this important dialogue, sharing insights that support progress in kidney, bladder, prostate, and upper tract urothelial cancer research.
From practical workshops to in-depth lectures, EMUC24 serves as a vital platform for innovation, gathering diverse expertise to explore best practices and emerging therapies in GU cancer care.
Let’s congratulate Katelijne, Rosemarijn, Luna, Marinka, and Orlane for their commitment to advancing cancer research and improving lives!
#EMUC24 #CureforCancer #CancerResearch #Oncology #KidneyCancer #BladderCancer #ProstateCancer #UpperTractUrothelialCancer
Binnen mijn promotietraject in het Amsterdam UMC onderzoek ik verschillende onderdelen van de diagnostiek naar en behandeling van prostaatkanker. Prostaatkanker is een van de meest voorkomende vormen van kanker bij mannen.
save lives with your donation
Every contribution helps fund critical research and advances treatments that change lives.
The Cure for Cancer Foundation depends entirely on income from donations, gifts and sponsorships. We receive no government subsidies, making your support invaluable for pioneering cancer research.
About us
Donate
Legal
